Sep 2026· European Heart Journal - Digital Health· Vol 7· 0 citations· 22 references
Medicine
TL;DR
Artificial intelligence-based CCTA analysis identified a large low-risk subgroup and a smaller subgroup at increased HF risk, supporting further evaluation of opportunistic HF assessment from CCTA.
Abstract
Abstract Aims Heart failure (HF) in non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is associated with poor prognosis but often under-recognized. Coronary computed tomography angiography (CCTA), increasingly used in NSTE-ACS, contains cardiopulmonary features not routinely assessed for HF. We evaluated whether an artificial intelligence (AI) algorithm applied to CCTA could identify HF likelihood in NSTE-ACS. Methods and results In this retrospective external validation study, the AI algorithm was applied without retraining or recalibration to CCTA scans from 1009 patients with NSTE-ACS in the VERDICT trial. Using a pre-specified threshold, patients were classified as low or high AI likelihood of HF. The primary outcome was HF during index hospitalization. The secondary outcome was post-discharge HF hospitalization among patients discharged alive without HF, with analyses adjusted for global registry of acute coronary events score >140 and severe coronary artery disease. Death was treated as a competing risk. Overall, 838 patients (83%) were classified as low AI likelihood and 171 (17%) as high. During index hospitalization, HF was diagnosed in 10 patients (1%) with low AI likelihood and 12 (7%) with high. Sensitivity was 55%, specificity 84%, positive predictive value 7%, and negative predictive value 99%. High AI likelihood was associated with increased risk of index HF (subdistribution hazard ratio, 5.39, 95% confidence interval (CI) 2.32–12.50). After discharge, HF hospitalization occurred in 25 patients (3%) with low AI likelihood and 14 (8%) with high. High AI likelihood remained associated with HF hospitalization (subdistribution hazard ratio 2.56, 95% CI 1.34–4.90). Conclusion AI-based CCTA analysis identified a large low-risk subgroup and a smaller subgroup at increased HF risk, supporting further evaluation of opportunistic HF assessment from CCTA.
ML-based models enabled accurate prediction of IHM in patients with NSTE-ACS at different stages of the diagnostic process and may improve risk stratification and clinical decision-making in real-world practice.
V. V. Ryabov, A. Nesova, A. Vishnevskiy et al.· JMIR Medical Informatics· 0 citations
Aim: Scoring systems used to risk stratify patients with suspected non-ST-segment elevation myocardial infarction (NSTEMI)/ unstable angina (UA) for clinical decision-making in the Emergency Department (ED) are validated for outcomes, mortality, or adverse events but not evaluated for their predictive accuracy of the s...
Bibitha Susan Varghese, N. M. Nedungalaparambil, L. Fischer et al.· Anatolian journal of emergen...· 0 citations
Objectives The Queen of Hearts (QoH) ECG artificial intelligence model has demonstrated improved sensitivity for detecting occlusion myocardial infarction (OMI) compared with STEMI criteria, but further validation is needed. We aimed to evaluate QoH's diagnostic performance in patients with chest pain at Swedish emerge...
T. Lindow, Axel Nyström, J. Forberg et al.· Journal of the American Coll...· 0 citations
Background Type 2 diabetes mellitus (T2DM) is associated with adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI). Despite emergency percutaneous coronary intervention (PCI), in-hospital heart failure (HF) remains an important complication. This study aimed to identify factors independe...
Mailidan Maimaitiniyazi, Muyesaier Maimaitiniyazi, Meiheliya Maisuti et al.· Frontiers in Endocrinology· 0 citations
Objective This retrospective study aimed to investigate the long-term prognostic value and risk stratification in Japanese patients with known or suspected coronary artery disease (CAD) using poststress phase entropy, an index of left ventricular (LV) dyssynchrony.Methods The patients were followed up for six years t...
Katsunori Fukumoto, S. Yoda, Yudai Tanaka et al.· Internal medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.